Reply: Directly Observed Therapy: A Possible Tool to Tackle Medication Nonadherence in the CVD Epidemic

We appreciate Drs. Mezue and Rangaswami’s interest in our State-of-the-Art Review paper [(1)][1] and would like to respond by making the following 4 points. First, we agree there is good evidence of directly observed therapy (DOT) specifically with infectious diseases (e.g., tuberculosis [TB] and